Vaughan Nelson Investment Management’s GE Aerospace GE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.8M Sell
114,540
-6,455
-5% -$2.02M 0.38% 109
2026
Q1
$34.3M Buy
120,995
+29,930
+33% +$9.41M 0.34% 110
2025
Q4
$28.1M Buy
91,065
+2,110
+2% +$635K 0.27% 120
2025
Q3
$26.8M Hold
88,955
0.24% 111
2025
Q2
$22.9M Buy
+88,955
New +$19.5M 0.21% 118
2018
Q1
Sell
-9,979
Closed -$835K 193
2017
Q4
$835K Hold
9,979
0.01% 190
2017
Q3
$1.16M Buy
9,979
+3,338
+50% +$404K 0.01% 187
2017
Q2
$860K Hold
6,641
0.01% 193
2017
Q1
$948K Hold
6,641
0.01% 177
2016
Q4
$1.01M Hold
6,641
0.01% 166
2016
Q3
$943K Sell
6,641
-3,130
-32% -$467K 0.01% 171
2016
Q2
$1.47M Hold
9,771
0.02% 158
2016
Q1
$1.49M Hold
9,771
0.02% 149
2015
Q4
$1.46M Hold
9,771
0.02% 145
2015
Q3
$1.18M Hold
9,771
0.02% 151
2015
Q2
$1.24M Buy
9,771
+1,607
+20% +$208K 0.02% 146
2015
Q1
$971K Buy
+8,164
New +$972K 0.01% 154

Other funds holding GE

Vaughan Nelson Investment Management's GE Position: Q2 2026 in Review

Vaughan Nelson Investment Management reduced its GE Aerospace (GE) stake by 5.3% in Q2 2026, selling an estimated $2.02M and leaving 114,540 shares worth $42.8M. The position accounts for 0.38% of the portfolio, ranked #109.

Vaughan Nelson Investment Management first reported a position in GE in Q1 2015 and has held it in 17 quarters since. 1,821 funds tracked by Wall St. Rank hold GE as of Q2 2026.

  • Vaughan Nelson Investment Management held 114,540 shares of GE Aerospace worth $42.8M as of Q2 2026.
  • Vaughan Nelson Investment Management sold 6,455 GE Aerospace shares in Q2 2026, an estimated $2.02M.
  • GE Aerospace made up 0.38% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #109 holding.
  • Vaughan Nelson Investment Management first reported a position in GE Aerospace in Q1 2015 and has held it in 17 quarters since.
  • 1,821 funds tracked by Wall St. Rank held GE Aerospace as of Q2 2026.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.